VerifiedBiotechnology· Founded 2005

Immunomic Therapeutics, Inc

Immunomic Therapeutics, Inc.(ITI) is a privately-held clinical stage biotechnology company pioneering the study of the Universal Intracellular Targeted Expression (UNITE) nucleic acid immunotherapy platform. This investigational technology has the potential to alter how we use immunotherapy for a number of diseases, including cancer, allergy and infectious diseases.

7-day free trial · no credit card

Rockville, United States22(11 to 50)$1M to <$10M2005immunomix.com LinkedIn

Verified contacts

26

available on Kipplo

LinkedIn employees

22

11 to 50 range

Open roles

—

no listings

Distinct roles

21

indexed titles

Tech stack

2

tools in use

Monthly traffic

446

organic / mo

Sign up free to see all 26 verified contacts at Immunomic Therapeutics, Inc

Free for 7 days · 50 credits · no card · only pay for verified records.

Decision-makers and verified team members

26 contacts with verified email or phone · masked until revealed.

Sign up free →

Showing 9 of 26 verified contacts

Top roles at Immunomic Therapeutics, Inc

21 distinct titles indexed · top 10 shown.

1()
1-,
1associate director, translational research
1chief executive officer
1chief scientific officer (cso)
1communications manager
1director of clinical operations
1director, business development
1director, cell therapy process development
1director, rna therapeutic development
+11more titles

Sign up to unlock all 26 contacts at Immunomic Therapeutics, Inc

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up to reveal 26 verified contacts at Immunomic Therapeutics, Inc

7-day trial · no credit card · cancel anytime · only pay for verified records.

Sign up free See pricing

Trusted by sales, marketing, and GTM engineering teams.

Immunomic Therapeutics, Inc | Kipplo Discover